Tislelizumab in combination with gemcitabine plus cisplatin as neoadjuvant therapy for lymph node-positive bladder cancer: Results of a prospective study

被引:0
|
作者
Lyu, Q. [1 ]
Yang, X. [1 ]
Cao, Q. [1 ]
Zhuang, J. [1 ]
机构
[1] Nanjing Med Univ, Dept Urol, Affiliated Hosp 1, Nanjing, Peoples R China
关键词
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
A0904
引用
收藏
页码:S1957 / S1957
页数:1
相关论文
共 50 条
  • [41] Axillary Lymph Node Ultrasound Following Neoadjuvant Chemotherapy in Biopsy-Proven Node-Positive Breast Cancer: Results from the SN FNAC Study
    Dominique Morency
    Sinziana Dumitra
    Elena Parvez
    Karyne Martel
    Mark Basik
    André Robidoux
    Brigitte Poirier
    Claire M. B. Holloway
    Louis Gaboury
    Lucas Sideris
    Sarkis Meterissian
    Jean-François Boileau
    Annals of Surgical Oncology, 2019, 26 : 4337 - 4345
  • [42] Axillary Lymph Node Ultrasound Following Neoadjuvant Chemotherapy in Biopsy-Proven Node-Positive Breast Cancer: Results from the SN FNAC Study
    Morency, D.
    Dumitra, S.
    Parvez, E.
    Basik, M.
    Boileau, J.
    ANNALS OF SURGICAL ONCOLOGY, 2019, 26 : S8 - S8
  • [43] Implementation of sentinel lymph node biopsy following neoadjuvant chemotherapy in clinically node-positive breast cancer
    Mele, Alessandra
    Alapati, Amulya
    Serres, Stephanie
    James, Ted
    ANNALS OF SURGICAL ONCOLOGY, 2019, 26 : 288 - 288
  • [44] Oncologic Outcomes of Sentinel Lymph Node Surgery After Neoadjuvant Chemotherapy for Node-Positive Breast Cancer
    Mara A. Piltin
    Tanya L. Hoskin
    Courtney N. Day
    John Davis
    Judy C. Boughey
    Annals of Surgical Oncology, 2020, 27 : 4795 - 4801
  • [45] Impact of Lymph Node Ratio and Adjuvant Therapy in Node-Positive Endometrioid Endometrial Cancer
    Fleming, Nicole D.
    Soliman, Pamela T.
    Westin, Shannon N.
    dos Reis, Ricardo
    Munsell, Mark
    Klopp, Ann H.
    Frumovitz, Michael
    Nick, Alpa M.
    Schmeler, Kathleen
    Ramirez, Pedro T.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2015, 25 (08) : 1437 - 1444
  • [46] Neoadjuvant Gemcitabine-Cisplatin Plus Radical Cystectomy-Pelvic Lymph Node Dissection for Muscle-invasive Bladder Cancer: A 12-year Experience
    Iyer, Gopa
    Tully, Christopher M.
    Zabor, Emily C.
    Bochner, Bernard H.
    Dalbagni, Guido
    Herr, Harry W.
    Donat, S. Machelle
    Russo, Paul
    Ostrovnaya, Irina
    Regazzi, Ashley M.
    Milowsky, Matthew, I
    Rosenberg, Jonathan E.
    Bajorin, Dean F.
    CLINICAL GENITOURINARY CANCER, 2020, 18 (05) : 387 - 394
  • [47] Gemcitabine plus cisplatin therapy, a safety regimen in advanced bladder cancer.
    Song, J
    Chung, H
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 452S - 452S
  • [48] Is neoadjuvant chemotherapy with gemcitabine plus cisplatin beneficial in patients with muscle-invasive bladder cancer?
    Yafi, Faysal A.
    Kassouf, Wassim
    EXPERT REVIEW OF ANTICANCER THERAPY, 2009, 9 (06) : 747 - 752
  • [49] The Combination of Gemcitabine and Carboplatin in Neoadjuvant Treatment of Bladder Cancer: A Pilot Study
    Dizdar, Omer
    Akbulut, Ziya
    Tuna, Savas
    Cavusoglu, Emel
    Ulusoy, Nuran A.
    Balbay, M. Derya
    UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, 2011, 21 (02): : 67 - 70
  • [50] Adjuvant Therapy in Lymph Node-Positive Vulvar Cancer: The AGO-CaRE-1 Study
    Mahner, Sven
    Jueckstock, Julia
    Hilpert, Felix
    Neuser, Petra
    Harter, Philipp
    de Gregorio, Nikolaus
    Hasenburg, Annette
    Sehouli, Jalid
    Habermann, Annika
    Hillemanns, Peter
    Fuerst, Sophie
    Strauss, Hans-Georg
    Baumann, Klaus
    Thiel, Falk
    Mustea, Alexander
    Meier, Werner
    du Bois, Andreas
    Griebel, Lis-Femke
    Woelber, Linn
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2015, 107 (03):